-
-
-
-
-
-
-
Ligand Pharma (LGND) Reiterated at Buy by Stifel After Chat With CEO, CFO
-
-
-
-
-
-
-
Ligand Pharma (LGND) PT Raised to $388 at BofA Securities
-
-
-
-
-
-
-
Ligand Pharma (LGND) PT Raised to $255 at Stifel
-
-
-
-
-
-
-
Ligand Pharma (LGND) PT Raised to $277 at Oppenheimer
-
-
-
-
-
-
-
RBC Capital Reiterates Outperform Rating on Ligand Pharma (LGND), Investor Day Preview
-
-
-
-
-
-
-
Ligand Pharma (LGND) PT Raised to $206 at H.C. Wainwright
-
-
-
-
-
-
-
Ligand Pharma (LGND) PT Raised to $162 at Oppenheimer
-
481,532 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


